Menu
Back to Journals » Drug Design, Development and Therapy » Volume 12
Review
Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 26,814 | Dovepress* | 18,726+ | 1,845 | 20,571 | |
| PubMed Central* | 8,088 | 1,400 | 9,488 | ||
| Totals | 26,814 | 3,245 | 30,059 | ||
| *Since 12 November 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar